Production (Stage)
Elixxer Ltd.
ELIXF
$0.0061
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -25.43% | 30.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.43% | 30.09% | |||
| Operating Income | 25.43% | -30.09% | |||
| Income Before Tax | 66.29% | -202.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 66.29% | -202.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 66.29% | -202.50% | |||
| EBIT | 25.43% | -30.09% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 66.26% | -202.74% | |||
| Normalized Basic EPS | 20.71% | -23.89% | |||
| EPS Diluted | 66.26% | -202.74% | |||
| Normalized Diluted EPS | 20.71% | -23.89% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||